XT
RCUS icon

XTX Topco’s Arcus Biosciences RCUS Stock Holding History

XTX Topco’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$265K Buy
+12,265
New +$265K ﹤0.01% 2594
2025
Q3 		– Sell
-35,998
Closed -$293K – 3142
2025
Q2 		$293K Buy
+35,998
New +$307K 0.01% 1448
2025
Q1 		– Sell
-18,434
Closed -$274K – 2977
2024
Q4 		$274K Buy
18,434
+7,239
+65% +$118K 0.02% 1299
2024
Q3 		$171K Sell
11,195
-27,566
-71% -$435K 0.01% 1491
2024
Q2 		$590K Buy
+38,761
New +$626K 0.05% 580
2023
Q4 		– Sell
-21,970
Closed -$394K – 2036
2023
Q3 		$394K Buy
21,970
+5,507
+33% +$111K 0.07% 549
2023
Q2 		$334K Buy
+16,463
New +$313K 0.06% 638
2023
Q1 		– Sell
-10,800
Closed -$223K – 1595
2022
Q4 		$223K Buy
+10,800
New +$297K 0.05% 774
2021
Q2 		– Sell
-9,648
Closed -$271K – 1042
2021
Q1 		$271K Buy
+9,648
New +$336K 0.13% 327

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

XTX Topco's RCUS Position: Q1 2026 in Review

XTX Topco opened a new position in Arcus Biosciences (RCUS) in Q1 2026: 12,265 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #2594 among its holdings. This is a return to the name: XTX Topco previously reported a position in RCUS as recently as Q2 2025.

XTX Topco first reported a position in RCUS in Q1 2021 and has held it in 9 quarters since. The position peaked at $590K in Q2 2024. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • XTX Topco held 12,265 shares of Arcus Biosciences worth $265K as of Q1 2026.
  • Arcus Biosciences was a new XTX Topco position in Q1 2026.
  • Arcus Biosciences made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2594 holding.
  • XTX Topco first reported a position in Arcus Biosciences in Q1 2021 and has held it in 9 quarters since.
  • XTX Topco's Arcus Biosciences position peaked at $590K in Q2 2024.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.